About State Line Treatment Services
Services
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine or Clonidine detoxification
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; Commission on Accreditation of Rehabilitation Facilities (CARF); SAMHSA certification for opioid treatment program (OTP)
Payment/Insurance/Funding Accepted
Medicaid
Special Programs/Groups Offered
Adult women; Adult men; Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Outreach to persons in the community; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug and alcohol oral fluid testing; Drug or alcohol urine screening; HIV testing; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education
Recovery Support Services
Housing services; Assistance with obtaining social services
Education and Counseling Services
Hepatitis education, counseling, or support; Substance use disorder education; Individual counseling; Group counseling; Family counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Sex Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Mental health services; Transportation assistance
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine or Clonidine detoxification
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; Commission on Accreditation of Rehabilitation Facilities (CARF); SAMHSA certification for opioid treatment program (OTP)
Payment/Insurance/Funding Accepted
Medicaid
Special Programs/Groups Offered
Adult women; Adult men; Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Outreach to persons in the community; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug and alcohol oral fluid testing; Drug or alcohol urine screening; HIV testing; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education
Recovery Support Services
Housing services; Assistance with obtaining social services
Education and Counseling Services
Hepatitis education, counseling, or support; Substance use disorder education; Individual counseling; Group counseling; Family counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Sex Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Mental health services; Transportation assistance
